Arunava Kali

1.1k total citations
47 papers, 703 citations indexed

About

Arunava Kali is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Arunava Kali has authored 47 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Arunava Kali's work include Antimicrobial Resistance in Staphylococcus (6 papers), Neonatal and Maternal Infections (5 papers) and Streptococcal Infections and Treatments (4 papers). Arunava Kali is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (6 papers), Neonatal and Maternal Infections (5 papers) and Streptococcal Infections and Treatments (4 papers). Arunava Kali collaborates with scholars based in India and Denmark. Arunava Kali's co-authors include R. Kalaivani, Noyal Mariya Joseph, A J Walt, Joshy M Easow, Shailesh Kumar, M Ravishankar, Martin S. Bojer, Weizhe Wang, Hanne Ingmer and Stephanie Fulaz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Plastic & Reconstructive Surgery and Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review.

In The Last Decade

Arunava Kali

45 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arunava Kali India 14 174 138 137 118 107 47 703
Min Dai China 17 294 1.7× 125 0.9× 66 0.5× 113 1.0× 187 1.7× 61 840
Chunmei Bao China 15 115 0.7× 105 0.8× 84 0.6× 131 1.1× 188 1.8× 27 529
Soichiro Kimura Japan 18 312 1.8× 200 1.4× 119 0.9× 173 1.5× 161 1.5× 46 808
B. Pron France 13 135 0.8× 236 1.7× 94 0.7× 221 1.9× 82 0.8× 16 875
Norma Velázquez‐Guadarrama Mexico 16 321 1.8× 94 0.7× 73 0.5× 117 1.0× 128 1.2× 46 826
Ayman Mubarak Saudi Arabia 18 252 1.4× 264 1.9× 150 1.1× 130 1.1× 101 0.9× 50 1.0k
Marie-Odile Husson France 16 178 1.0× 61 0.4× 90 0.7× 110 0.9× 108 1.0× 20 625
Norihisa Yamamoto Japan 17 162 0.9× 152 1.1× 133 1.0× 170 1.4× 313 2.9× 49 777
Hamed Ebrahimzadeh Leylabadlo Iran 15 467 2.7× 154 1.1× 74 0.5× 141 1.2× 130 1.2× 52 947

Countries citing papers authored by Arunava Kali

Since Specialization
Citations

This map shows the geographic impact of Arunava Kali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arunava Kali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arunava Kali more than expected).

Fields of papers citing papers by Arunava Kali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arunava Kali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arunava Kali. The network helps show where Arunava Kali may publish in the future.

Co-authorship network of co-authors of Arunava Kali

This figure shows the co-authorship network connecting the top 25 collaborators of Arunava Kali. A scholar is included among the top collaborators of Arunava Kali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arunava Kali. Arunava Kali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Weizhe, Martin S. Bojer, Arunava Kali, et al.. (2025). Characterization of agr-like Loci in Lactiplantibacillus plantarum and L. paraplantarum and Their Role in Quorum Sensing and Virulence Inhibition of Staphylococcus aureus. Probiotics and Antimicrobial Proteins. 17(4). 2332–2347. 1 indexed citations
2.
Kali, Arunava, et al.. (2024). Curcumin as a Promising Therapy for COVID-19: A Review. 19. 2–2. 3 indexed citations
4.
Kalaivani, R., et al.. (2018). Evaluation of procalcitonin as a diagnostic marker in neonatal sepsis. Indian Journal of Pathology and Microbiology. 61(1). 81–81. 9 indexed citations
5.
Kali, Arunava, et al.. (2016). EndNote as document manager for summative assessment. Journal of Postgraduate Medicine. 62(2). 124–125. 10 indexed citations
6.
Kali, Arunava, et al.. (2016). Antibacterial synergy of curcumin with antibiotics against biofilm producing clinical bacterial isolates. PubMed. 7(3). 93–93. 104 indexed citations
7.
Kali, Arunava, et al.. (2016). Aeromonas hydrophila meningitis and fulminant sepsis in preterm newborn: A case report and review of literature. Indian Journal of Medical Microbiology. 34(4). 544–547. 19 indexed citations
8.
Kali, Arunava, et al.. (2015). MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII FROM NOSOCOMIAL URINARY TRACT INFECTION: A CASE REPORT. 1 indexed citations
9.
Kali, Arunava. (2015). Microbial infection imaging: A novel diagnostic approach. Indian Journal of Nuclear Medicine. 30(2). 189–189. 1 indexed citations
10.
Kali, Arunava, et al.. (2015). Hepcidin - A novel biomarker with changing trends. Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review. 9(17). 35–35. 39 indexed citations
11.
Kali, Arunava. (2015). Teixobactin: A Novel Antibiotic in Treatment of Gram Positive Bacterial Infections. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. 9(3). DL01–DL01. 9 indexed citations
12.
Kali, Arunava, et al.. (2015). A cost-effective carbohydrate fermentation test for yeast using microtitre plate. Indian Journal of Medical Microbiology. 33(2). 293–295. 10 indexed citations
13.
Kali, Arunava, et al.. (2015). Utility of cord blood culture in early onset neonatal sepsis. Australasian Medical Journal. 8(8). 263–267. 16 indexed citations
14.
Kali, Arunava. (2015). Antibiotics and bioactive natural products in treatment of methicillin resistant Staphylococcus aureus: A brief review. Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review. 9(17). 29–29. 74 indexed citations
15.
Kali, Arunava. (2015). Human Microbiome Engineering: The Future and Beyond. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. 9(9). DE01–4. 8 indexed citations
16.
Kali, Arunava, et al.. (2015). Cadazolid: A new hope in the treatment of Clostridium difficile infection. Australasian Medical Journal. 8(8). 253–262. 23 indexed citations
17.
Kali, Arunava. (2014). A COST-EFFECTIVE TECHNIQUE OF YEAST STOCK CULTURE MAINTENANCE IN LABORATORY. International Journal of Pharma and Bio Sciences. 1 indexed citations
18.
Kali, Arunava. (2014). CRYPTOSPORIDIOSIS IN INDIA. International Journal of Pharma and Bio Sciences. 3 indexed citations
19.
Kali, Arunava. (2013). Significance of Serum L-fucose Glycoprotein as Cancer Biomarker in Head and Neck Malignancies without Distant Metastasis. SHILAP Revista de lepidopterología. 7(12). 2818–20. 14 indexed citations
20.
Kali, Arunava. (2013). Bacteriophage types of methicillin-resistant Staphylococcus aureus in a tertiary care hospital. Australasian Medical Journal. 6(10). 496–503. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026